BlackRock »

Taysha Gene Therapies shares owned by BlackRock

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $27M 14M 2.01

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Taysha Gene Therapies

BlackRock
BlackRock
RA Capital Management
VR Adviser
Morgan Stanley
Vanguard Group
Siren
Octagon Capital Advisors
Baker Bros. Advisors
Geode Capital Management
State Street Corporation
Jpmorgan Chase & Co
Citadel Advisors
Deutsche Bank Aktiengesellschaft
Northern Trust

View all funds holding Taysha Gene Therapies